BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10692757)

  • 21. Advances in the pathogenesis and treatment of acute coronary syndromes.
    Thompson CA; Danzell JD; Hanley HG
    J La State Med Soc; 1999 May; 151(5):272-7. PubMed ID: 10363482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: complementary or competing therapies?
    White HD
    J Invasive Cardiol; 2000 Feb; 12 Suppl A():6A-13A. PubMed ID: 10731290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Which, when, how?].
    Juárez Herrera U
    Arch Cardiol Mex; 2001; 71 Suppl 1():S85-90. PubMed ID: 11565353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.
    Bosch X; Marrugat J
    Cochrane Database Syst Rev; 2001; (4):CD002130. PubMed ID: 11687143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antithrombotic therapy for non-ST segment elevation myocardial infarction].
    Hölschermann H
    Hamostaseologie; 2006 May; 26(2):106-13. PubMed ID: 16676052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-molecular-weight heparins and glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Ferguson J
    J Invasive Cardiol; 2004 Mar; 16(3):136-44. PubMed ID: 15152164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of IIb/IIIa receptor blockade in patients with unstable angina.
    Vahanian A; Michaud P; Garbarz E
    Semin Interv Cardiol; 1999 Jun; 4(2):61-6. PubMed ID: 10473874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction.
    Crosbie DJ
    Emerg Med Australas; 2005; 17(5-6):500-10. PubMed ID: 16302944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition.
    Ferguson JJ; Waly HM; Wilson JM
    Eur Heart J; 1998 Apr; 19 Suppl D():D3-9. PubMed ID: 9597517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina.
    Steinhubl SR; Moliterno DJ
    Heart Vessels; 1997; Suppl 12():148-55. PubMed ID: 9476567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral platelet glycoprotein IIb/IIIa inhibition.
    Newby LK; McGuire DK
    Curr Cardiol Rep; 2000 Sep; 2(5):372-7. PubMed ID: 10980903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet and antithrombin therapies in the acute coronary syndromes.
    Alexander JH; Harrington RA
    Curr Opin Cardiol; 1997 Jul; 12(4):427-37. PubMed ID: 9263656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction.
    Weitz JI; Bates SM
    Arch Intern Med; 2000 Mar; 160(6):749-58. PubMed ID: 10737274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tirofiban (Aggrastat). A non-peptide glycoprotein IIb/IIIa receptor inhibitor].
    Rasmussen S; Husted SE
    Ugeskr Laeger; 2001 Jan; 163(4):461-5. PubMed ID: 11218789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of unstable angina: the role of platelet inhibitors and anticoagulants.
    Cohen M
    J Invasive Cardiol; 1999 Mar; 11(3):147-59. PubMed ID: 10745504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wall passivation for unstable angina.
    Lettino M; Dailey-Sterling F; Badimon L; Chesebro JH; Badimon JJ
    Semin Interv Cardiol; 1996 Mar; 1(1):60-6. PubMed ID: 9552495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina.
    Ageno W; Turpie AG
    G Ital Cardiol; 1999 Nov; 29(11):1357-65. PubMed ID: 10609142
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral glycoprotein IIb/IIa antagonists for unstable angina--is there still a chance for the oral substances?
    Darius H
    Thromb Res; 2001 Sep; 103 Suppl 1():S117-24. PubMed ID: 11567679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.